In contrast, Jiang et al. observed a decrease in RhoGDI expression in tumors by quantitative RT-PCR and immunohistochemistry staining, when comparing 120 breast tumor samples with 32 normal tissue samples [5]. The gene discussed is ARHGDIA; the disease is breast neoplasm.